Co-Diagnostics, Inc. — Form 8-K
Filed September 16, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 8/100
What the filing says
Co-Diagnostics, Inc. filed an 8-K on September 16, 2026, disclosing information under Regulation FD (Item 7.01) with 14 graphic exhibits and XBRL financial data files. The filing contains no accessible substantive details in the provided text — only document metadata, file names, and company registration information. No specific dollar amounts, counterparties, transactions, share counts, or business developments are disclosed in the available filing materials.
Why this rating
Filing is routine disclosure with no substantive business event disclosed in accessible text. Company size $10M makes even small undisclosed developments potentially material, but no concrete facts are provided to assess.
Extracted items
- 7.01 Reg FD disclosure
- 9.01 exhibits
See more from September 16, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.